Cuban Anti-Cancer Meds
in Malaysia
Doctors of Kuala Lumpur
Hospital's Cancer
Research Center are
testing in this country
a therapeutical vaccine
to treat malignant
tumors, developed by
scientists of the Cuban
Molecular Immunology
Center (CIM).
The vaccine EGF-P64K,
against cancer, is not
prophylactic, but
therapeutic, to fight
the growing carcinogenic
cells, doctors Gisela
Gonzalez, the project's
manager and Carmen
Barroso, oncologist of
the CIM clinic research
board of directors,
explained after starting
the testing stage.
"Relations between Cuba
and Malaysia began many
years ago, and we will
maintain our support of
this project against
cancer," Malaysian
Health Vice-minister
Abdul Latiff Ahmad said.
Based on the Epidermal
Growth Factor, the Cuban
product seeks to improve
the life quality of
patients with advanced
lung cancer.
Malaysian specialists
will be testing the
Cuban vaccine on 230
voluntary patients from
14 hospitals of
Malaysia, over two and a
half years. |
|
